Pulmonary embolism (PE) remains a major cause of cardiovascular morbidity and mortality worldwide. It occurs when thrombotic material—most often ...
Analysis is first to compare health system-based electronic health record data for treatment of pulmonary embolism with interventional devices MARLBOROUGH, Mass., Oct. 24, 2023 /PRNewswire/ -- Data ...
VIENNA — The optimal course of treatment when managing acute, high-risk pulmonary embolism (PE) remains a contentious topic among respiratory specialists. Systemic thrombolysis, specifically using ...
As an interventional radiologist at Palmetto General Hospital, I have over 15 years of experience treating venous thromboembolic disease and have comp ...
New data finds AlphaVac F1885 System safe in patients with acute intermediate-risk pulmonary embolism (PE) and provides significant improvement in right ventricular function and reduction in clot ...
The right treatment for a pulmonary embolism depends on the size of the blood clot, complications you might be experiencing, and your risk of future blood clots. Options may include medications or ...
A pulmonary embolism (PE) is a blockage within an artery in the lungs. It is a potentially life threatening condition that requires prompt diagnosis and treatment. Pregnancy causes changes to hormones ...
Amid rapid changes in the field of acute pulmonary embolism (PE) treatment, the American Heart Association (AHA) has released a scientific statement summing up the current state of interventional ...
Penumbra took the TCT (Transcatheter Cardiovascular Therapeutics) by storm on Sunday with the results of its landmark STORM-PE randomized controlled trial. The Alameda, CA-based company reported that ...
The FlowTriever percutaneous mechanical thrombectomy system (Inari Medical) is safe and provides immediate benefits to patients with acute pulmonary embolism (PE), interim results of the real-world ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results